Amylyx Pharmaceuticals, Inc. (AMLX) Operating margin 2021–2024
Amylyx Pharmaceuticals, Inc. (AMLX) operating margin by fiscal year — reported operating income divided by reported revenue.
-360.2%FY2024 · since FY2021: -29013.3% → -360.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -360.2% | -370.4 pp |
| FY2023 | 10.2% | +915.9 pp |
| FY2022 | -905.7% | +28107.6 pp |
| FY2021 | -29013.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMLX financial trends
AMLX RevenueAMLX Net incomeAMLX Net marginAMLX Gross profitAMLX Gross marginAMLX Operating incomeAMLX Operating cash flowAMLX Free cash flowAMLX Capital expendituresAMLX Return on equityAMLX Stock buybacksAMLX Dividends paidAMLX Total assetsAMLX Total liabilitiesAMLX Shareholders’ equityAMLX overview →